e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Have we advanced in the treatment of sleep disordered breathing?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can we predict successful CPAP treatment in upper airways resistance syndrome?
T. Davies, A. Bibby, S. Backway, M. Juniper, A. Kerry, A. Stanton (Swindon, United Kingdom)
Source:
Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Session:
Have we advanced in the treatment of sleep disordered breathing?
Session type:
Thematic Poster Session
Number:
2591
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Davies, A. Bibby, S. Backway, M. Juniper, A. Kerry, A. Stanton (Swindon, United Kingdom). Can we predict successful CPAP treatment in upper airways resistance syndrome?. Eur Respir J 2013; 42: Suppl. 57, 2591
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016
Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Are respiratory events and/or arousals during each sleep stage different by upper airway collapsibility?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015
A case series of CPAP therapy – Who declines treatment?
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Nasal inflammation and sleep quality with continuous positive airway pressure (CPAP) therapy in obstructive sleep apnoea
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Does CPAP therapy affect sleep time in patients with obstructive sleep apnea? A prospective study
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Maximum pressures from auto-CPAP devices predict oral appliance treatment success in non-adherent obstructive sleep apnoea patients
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Optimal pressure determination for CPAP in the treatment of obstructive sleep apnea syndrome (OSAS). Comparison of prediction equations and autoCPAP titration
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013
Single center experience of selective upper airway stimulation in 45 patients with obstructive sleep apnea
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
The efficacy of oral appliance in patients with severe obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Does CPAP treatment lead to gastroesophageal reflux in moderate and severe OSA cases?
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014
HFNC: A new therapeutic approach in patients with chronic heart failure and Cheyne-Stokes breathing
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Effect of nasal CPAP on nasal symptoms in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
Performance assessment of a novel medical device for home monitoring of CPAP treatment in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept